Northern Trust Corp Dia Medica Therapeutics Inc. Transaction History

Northern Trust Corp

$586 Billion
Q2 2024

A detailed history of Northern Trust Corp transactions in Dia Medica Therapeutics Inc. stock. As of the latest transaction made, Northern Trust Corp holds 120,389 shares of DMAC stock, worth $529,711. This represents 0.0% of its overall portfolio holdings.

Number of Shares

120,389

Previous 127,819 5.81%

Holding current value

$529,711

Previous $354,000 0.28%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$2.16 - $3.66 $16,048 - $27,193	-7,430 Reduced 5.81%	120,389 $355,000
Q1 2024 May 14, 2024	SELL	$2.58 - $3.23 $15,000 - $18,779	-5,814 Reduced 4.35%	127,819 $354,000
Q4 2023 Feb 13, 2024	BUY	$2.05 - $2.99 $90,062 - $131,359	43,933 Added 48.98%	133,633 $379,000
Q3 2023 Nov 13, 2023	BUY	$2.56 - $4.4 $19,302 - $33,176	7,540 Added 9.18%	89,700 $231,000
Q2 2023 Aug 11, 2023	SELL	$1.53 - $4.4 $13,257 - $38,126	-8,665 Reduced 9.54%	82,160 $354,000
Q1 2023 May 15, 2023	SELL	$1.32 - $1.89 $2,960 - $4,239	-2,243 Reduced 2.41%	90,825 $138,000
Q4 2022 Feb 13, 2023	BUY	$1.13 - $1.62 $3,179 - $4,558	2,814 Added 3.12%	93,068 $147,000
Q3 2022 Nov 14, 2022	SELL	$1.2 - $2.07 $13,740 - $23,701	-11,450 Reduced 11.26%	90,254 $112,000
Q2 2022 Aug 12, 2022	BUY	$1.86 - $2.62 $3,277 - $4,616	1,762 Added 1.76%	101,704 $206,000
Q1 2022 May 13, 2022	SELL	$2.29 - $3.88 $3,070 - $5,203	-1,341 Reduced 1.32%	99,942 $250,000
Q4 2021 Feb 08, 2022	BUY	$3.43 - $4.65 $53,895 - $73,065	15,713 Added 18.36%	101,283 $378,000
Q3 2021 Nov 15, 2021	BUY	$3.1 - $4.32 $1,162 - $1,620	375 Added 0.44%	85,570 $343,000
Q2 2021 Aug 13, 2021	BUY	$4.45 - $9.91 $752 - $1,674	169 Added 0.2%	85,195 $379,000
Q1 2021 May 12, 2021	SELL	$7.76 - $10.43 $279,072 - $375,094	-35,963 Reduced 29.72%	85,026 $778,000
Q4 2020 Feb 11, 2021	BUY	$4.13 - $10.14 $17,436 - $42,811	4,222 Added 3.62%	120,989 $1.23 Million
Q3 2020 Nov 16, 2020	BUY	$3.91 - $7.15 $81,703 - $149,406	20,896 Added 21.8%	116,767 $495,000
Q2 2020 Aug 14, 2020	BUY	$2.6 - $7.32 $216,855 - $610,531	83,406 Added 669.12%	95,871 $664,000
Q1 2020 May 14, 2020	BUY	$2.25 - $5.64 $28,046 - $70,302	12,465 New	12,465 $35,000

Others Institutions Holding DMAC

# of Institutions

Shares Held

3.87M

Call Options Held

1.3K

Put Options Held

View Full List

About DiaMedica Therapeutics Inc.

Ticker DMAC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,443,100
Market Cap $116M
Description
DiaMedica Therapeutics Inc., a clinical stage biopharmaceutical company, develops treatments for neurological and kidney diseases. The company's lead drug candidate is DM199, a recombinant human tissue kallikrein-1 protein, which is in Phase 2 REDUX trial for the treatment of patients with moderate or severe chronic kidney disease caused by Type...

More about DMAC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account

Northern Trust Corp Dia Medica Therapeutics Inc. Transaction History